You cannot add another "Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer" to your cart. View cart

Article: Proteasome inhibitors in multiple myeloma and other haematological malignancies

€3.03

SKU: product-article-20861 Category: General

Description
Reviews (0)

Description

Proteasome inhibitors in multiple myeloma and other haematological malignancies

Reviews

There are no reviews yet.

Be the first to review “Article: Proteasome inhibitors in multiple myeloma and other haematological malignancies”

You must be logged in to post a review.

Top

Article: Proteasome inhibitors in multiple myeloma and other haematological malignancies

Description

Reviews

Related products

Article: Highlights in digestive oncology

Article: Highlights in melanoma

Article: Highlights in squamous cell carcinoma of the head and neck

Article: INTRODUCTION